Despite PSA screening and the control by radical prostatectomy, patients treatment fails and have a PSA recurrence.

作者信息

Lotan Yair

机构信息

Department of Urology, The University of Texas Southwestern Medical Center, Dallas, TX 75309-9110, USA.

出版信息

Eur Urol. 2007 Aug;52(2):453-4.

PMID:17674436

Abstract

摘要

相似文献

Despite PSA screening and the control by radical prostatectomy, patients treatment fails and have a PSA recurrence.

Eur Urol. 2007 Aug;52(2):453-4.

This paper evaluates the natural history of prostate cancer in heterogeneous cohort of men treated with HT.

Eur Urol. 2007 Aug;52(2):453.

Prostate cancer-specific survival in men treated with hormonal therapy after failure of radical prostatectomy.

Eur Urol. 2007 Aug;52(2):446-52. doi: 10.1016/j.eururo.2006.11.027. Epub 2006 Nov 20.

Prospective study evaluating postoperative radiotherapy plus 2-year androgen suppression for post-radical prostatectomy patients with pathologic T3 disease and/or positive surgical margins.

Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):407-12. doi: 10.1016/j.ijrobp.2008.11.007. Epub 2009 Feb 11.

Long-term outcome of detectable PSA levels after radical prostatectomy.

Prostate Cancer Prostatic Dis. 2005;8(2):163-6. doi: 10.1038/sj.pcan.4500788.

Efficacy of salvage radiotherapy plus 2-year androgen suppression for postradical prostatectomy patients with PSA relapse.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):983-9. doi: 10.1016/j.ijrobp.2008.12.049. Epub 2009 May 4.

Time to prostate-specific antigen nadir after androgen suppression therapy for postoperative or postradiation PSA failure and risk of prostate cancer-specific mortality.

Urology. 2008 Jan;71(1):136-40. doi: 10.1016/j.urology.2007.08.028.

Local control and long-term disease-free survival for stage D1 (T2-T4N1-N2M0) prostate cancer after radical prostatectomy in the PSA era.

Urology. 2007 Oct;70(4):723-7. doi: 10.1016/j.urology.2007.05.014.

[Surgical and medical treatment for localized prostate cancer].

Gan To Kagaku Ryoho. 2007 Jul;34(7):1002-5.

Persistent prostate-specific antigen expression after neoadjuvant androgen depletion: an early predictor of relapse or incomplete androgen suppression.

Urology. 2006 Oct;68(4):834-9. doi: 10.1016/j.urology.2006.04.016.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验